From Issue  Summer | Fall 2014

Vaccine leads to better survival, bigger catfish

MSU scientists have developed a vaccine to protect catfish from commonly occurring bacteria that can cause death. During their first growing season, every catfish fingerling raised in the Mississippi Delta will be exposed to Edwardsiella ictaluri, the bacteria that causes enteric septicemia, or ESC. MSU’s vaccine and delivery method were developed at the Thad Cochran Warmwater Aquaculture Center and received a provisional patent in 2013.

By: Vanessa Beeson

The initial catfish vaccine delivery system, designed by MSU’s agricultural and biological engineering team, travels from pond to pond and can hold up to 1000 pounds of feed. (Photo by David Ammon)


In 2013, catfish farms covered 48,600 surface acres of ponds across the state of Mississippi. The production across 125 operations totaled $178 million. ESC is estimated to reduce production by 25-30 percent costing the industry $30-40 million annually.

“This vaccine has the potential to fundamentally improve the economic viability of the catfish industry because of its positive effects on survival, growth, and feed conversion,” said Wes Burger, associate director of the Mississippi Agricultural and Forestry Experiment Station. “Mississippi State University and MAFES are focused on developing a commercialization strategy that will enable catfish producers to operate more efficiently with increased profitability.”

The Disease


ESC outbreaks typically occur in late summer or early fall as water temperatures begin to cool. Some ESC cases in infected catfish are mild while other cases lead to death. ESC causes a red rash and internal and external hemorrhaging, while an accumulation of fluid causes the catfish’s abdomen to swell. At this point, the catfish either clears the infection or it transitions into a chronic disease that localizes in the brain. It can cause a hole in the head exposing the brain, eventually leading to death. The chronic infection occurs in, and subsequently kills, five to 20 percent of the surviving population that goes through an outbreak. Fish that are exposed to the pathogen and survive develop an immune response and are subsequently protected from future exposure.

The spread of the bacteria can be slowed by cutting off feed during the spring and fall when the chance of an outbreak is greater. However, not feeding the catfish slows growth and increases the time required to produce a marketable-sized fish. Growers can also use medicated feed to control losses but medicated feeds are expensive and infections can be difficult to treat because sick fish do not eat once clinical signs of the disease are present.

The Vaccine


Vaccination protects the catfish by exposing them to a weakened form of the bacteria that stimulates development of an immune response without causing the disease. When vaccinated fish are later exposed to the fully virulent wild strain, their immune system is able to prevent infection. The vaccination allows growers to continue to feed throughout the fall and achieve greater weight gains and full production.

In 2008, David Wise, MAFES aquaculture scientist developed the live-attenuated vaccine and developed a method of delivering the vaccine orally with commercially available feed. Over the next few years, the new oral delivery method was shown safe and effective in laboratory tests, small pond trials, and ultimately, commercial-scale field trials. Protocols for vaccine production and processing were developed and validated in the field trials. By 2012, the team was using a catfish vaccine delivery system developed by MSU agricultural and biological engineers in field trials. In 2014, the team used a new commercial-scale delivery system developed by the same group.

In order to protect catfish against ESC, researchers took an active culture from sick catfish in the Delta and weakened it. Once weakened, bacteria lose the ability to cause disease and instead create a very mild sub-clinical infection that immunizes the catfish. The catfish clears the mild infection and is protected against subsequent infections.

“We came up with the idea because one of the natural routes of infection is when catfish ingest the bacteria while feeding,” Wise said. “If the catfish acquires the disease through feeding, why not vaccinate it through feeding?”

David Wise, research professor and coordinator of the Thad Cochran National Warmwater Aquaculture Center at the ponds where vaccines are delivered in late July. (Photo by David Ammon)

David Wise, research professor and coordinator of the Thad Cochran National Warmwater Aquaculture Center at the ponds where vaccines are delivered in late July. (Photo by David Ammon)

Bacteria outbreaks typically occur in the fall. The only time researchers can manipulate the catfish is when they leave the hatchery as fry or leave the nursery pond as adult catfish. Previously, fry had been vaccinated through immersion baths at seven to ten days old. The fry were too young with underdeveloped immunity so the vaccine, while providing some protection, was not considered effective. The immersion baths as the fish left the hatchery weren’t effective and fish coming out of the nursery ponds were already exposed to the bacteria.

The new vaccine and method allowed researchers to vaccinate a fully developed fish in the nursery pond.

There is a window of time between mid-July and mid-August when researchers vaccinate the catfish. The vaccine needs to be administered before the pond temperature dips below 28 degrees Celsius. ESC thrives below that temperature and that is when outbreaks typically occur.

The catfish must be 50 to 70 days old and able to eat the feed pellets. The feed is a carrier for the vaccine. If the catfish doesn’t eat, it doesn’t get vaccinated.

The Delivery Method


The team started off mixing the vaccine and feed in a little bucket in a small pond. They ran a study and it worked.

“A lot of things you do in disease research don’t work,” Wise said. “I haven’t seen anything like this. Quite often, we identify treatments that don’t work.”

The team proved the concept in five-gallon buckets but needed a better delivery system.

“You can’t vaccinate a 10-acre pond with a five-gallon bucket,” Wise said. “We had to come up with a method of mixing and administering the vaccine in 500, 800, or 1000 pounds of feed at a time.”


You can't vaccinate a 10-acre pond with a five-gallon bucket," Wise said. "We had to come up with a method of mixing and administering the vaccine in 500, 800, or 1000 pounds of feed at a time.

David Wise


The challenge lied in the vaccine itself. It has to be live to work. Once the vaccine is absorbed into the feed, researchers have 15 to 20 minutes before it starts losing viability. The team used a modified seed coater mounted onto a conventional blower on 1-acre ponds. They were able to mix up 150 pounds of feed in a batch but needed something on a commercial scale. Wise reached out to MSU’s agricultural and biological engineering department. Jeremiah Davis, MAFES agricultural engineer, worked with research associates to develop the first catfish vaccine delivery system. They finished the prototype in six months just in time to start vaccinating the fish.

The feed is loaded into a modified feeder and then passes through a system where the live vaccine is added; the feed absorbs the vaccine and runs through an airlock system that blows the feed into the pond. The delivery system is on a trailer so it can be moved from pond to pond. The first delivery system holds up to 1000 pounds of feed and can administer feed to two 8-acre ponds before reloading. The engineering team recently finished work on a larger catfish vaccine delivery system that holds 2000 pounds of feed and feed up to four 8-acre ponds before reloading. They tweaked some of the design based on what they learned the first time around.

“Everything worked well the first time around,” Davis said. “There are a few things we tweaked. The main problem with the prototype was the feed getting clogged in the airlock system. Dr. Wise found a feed that is less tacky and we’ve modified the new system with a larger airlock. The bottom of the feeder is now rounded instead of triangular, which should help as well.”

The Results


Researchers estimate about 75 percent of a pond population ingests the feed and subsequent vaccine. The dose is safe and consistent. It only takes one dose to vaccinate the catfish.

“We are seeing great results even though we aren’t vaccinating 100 percent of the population,” Wise said. “It gets into the herd immunity concept, but with schools of catfish. By vaccinating a large percentage of the population, we prevent the increase of pathogen levels in the pond. This protects the catfish that haven’t been immunized.”

Survival and size of the catfish both increased as a result of the vaccine.

“It’s a tremendous night and day difference between vaccinated and non-vaccinated catfish,” Wise said. “It depends on the challenge but the relative percent survival rate is usually greater than 90 percent. Typically we’ll get 50-80 percent mortality in the control group and 2-5 percent mortality in the vaccinated group.”

“In an aquaculture study, if you have a treatment effect that really improves survival, typically your fish get smaller. Economic returns are based on a balance between size and density,” Wise said. “You could have 100 percent survival in smaller fish and actually make less money because there is a sliding scale on how catfish are priced. A small catfish is worth less than a larger catfish. In this study, which is very unusual, we had twice as many catfish and they were 20 percent larger.”

The feed conversion ratio was also reduced from approximately 2.5 to 1.5, meaning that it takes a full pound less feed to produce a pound of fish. The team has seen similar results in repeated pond trials that have resulted in 2-3 fold increases in projected gross sales.

“The entire project has been a collaborative effort among many different programs,” Wise said. “The USDA’s National Biological Control Laboratory developed protocols for the commercial fermentation of the vaccine and is currently producing the vaccine for use in field trials. The MSU Agricultural and Biological Engineering Department in conjunction with the USDA ARS Poultry Research Unit engineered the delivery system. The MSU College of Veterinary Medicine has genetically characterized the vaccine isolate and is using the information to develop a rapid molecular test to detect and quantify the vaccine in tissue and environmental samples.”

The data required to support a USDA licensing application that would make the vaccine commercially available is currently being collected in the commercial-scale field trials.



Sections